Brief: Resonance Health Says Mitchell Wells To Transition To Role Of MD
28/06/2021 02:09
June 28 (Reuters) - Resonance Health Ltd RHT.AX :
* MITCHELL WELLS TO TRANSITION TO ROLE OF MD, FROM CURRENT
ROLE AS
EXECUTIVE DIRECTOR
Source text for Eikon: ID:nASXbR7FzF
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsBrief: Resonance Health Halts Trading In Resonance Health Securities Pending Announcement
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million